Get started
Author

Daniel J. García-Domínguez

Observed names: D J García-Domínguez, Daniel García-Domínguez, Daniel García‑Domínguez, Daniel J García-Domínguez, Daniel J. Garcia-Dominguez, Daniel Jose García-Domínguez, Daniel José García-Domínguez, García-Domínguez, D. J.
Observed institutions: Consejo Superior de Investigaciones Científicas, Universidad de Salamanca, Instituto Cajal, Hospital Universitario Virgen Macarena, Instituto de Biomedicina de Sevilla, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación del Cáncer, Hospital Universitario Virgen del Rocío, Centro de Investigación Biomédica en Red de Cáncer, Instituto de Biología Molecular y Celular del Cáncer de Salamanca, Imperial College London, Universidad de Sevilla
ORCID: 0000-0001-8150-2747
Observed ORCID: 0000-0001-8150-2747
OpenAlex ID: A5010454411
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
2020 · Lourdes Hontecillas-Prieto, Rocío Flores-Campos, et al. · Frontiers in Genetics · 196
PDF
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma
2011 · C Mackintosh, J L Ordóñez, et al. · Oncogene · 116
PDF
WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells
2012 · C Mackintosh, D J García-Domínguez, et al. · Oncogene · 65
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis
2020 · Sara Sánchez-Molina, Elisabet Figuerola-Bou, et al. · Science Advances · 40
PDF
The Clinical Relevance of Molecular Genetics in Soft Tissue Sarcomas
2010 · José Luis Ordóñez, Daniel Osuna, et al. · Advances in Anatomic Pathology · 33
Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics
2022 · Daniel J. García-Domínguez, Lourdes Hontecillas-Prieto, et al. · Cancers · 31
The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
2018 · Daniel Jose García-Domínguez, Lourdes Hontecillas-Prieto, et al. · Oncotarget · 29
PDF
Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer
2024 · Daniel J. García-Domínguez, Soledad López-Enríquez, et al. · International Journal of Molecular Sciences · 27
PDF
Stabilization ofDll1mRNA by Elavl1/HuR in neuroepithelial cells undergoing mitosis
2011 · Daniel J. García-Domínguez, Dominique Morello, et al. · Molecular Biology of the Cell · 24
PDF
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1
2022 · Daniel J. García-Domínguez, Nabil Hajji, et al. · Oncogene · 21
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma
2021 · Daniel J. García-Domínguez, Nabil Hajji, et al. · Oncogene · 20
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
2023 · María Luisa Sánchez-León, Carlos Jiménez-Cortegana, et al. · International Journal of Molecular Sciences · 19
PDF
Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review)
2024 · Carlos Jiménez‑Cortegana, Cristian Gutiérrez‑García, et al. · International Journal of Oncology · 17
PDF
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis
2022 · Natalia Palazón-Carrión, Alejandro Martín García-Sancho, et al. · Clinical Cancer Research · 17
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
2017 · Lourdes Hontecillas-Prieto, Daniel J. Garcia-Dominguez, et al. · Oncotarget · 17
PDF
RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-κB pathway, independently of the fusion oncoprotein
2016 · Inmaculada Hernandez-Muñoz, Elisabeth Figuerola, et al. · Oncotarget · 16
PDF
Innovative Therapies in Ewing Sarcoma
2013 · Ana Teresa Amaral, José Luis Ordóñez, et al. · Advances in Anatomic Pathology · 16
Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
2022 · Sara Sánchez-Molina, Elisabet Figuerola-Bou, et al. · Cancers · 14
The Bitter Side of Epigenetics: Variability and Resistance to Chemotherapy
2018 · Nabil Hajji, Daniel J García-Domínguez, et al. · Epigenomics · 14
PDF
Obesity and Risk for Lymphoma: Possible Role of Leptin
2022 · Carlos Jiménez-Cortegana, Lourdes Hontecillas-Prieto, et al. · International Journal of Molecular Sciences · 13
PDF
Leptin and Leptin Signaling in Multiple Sclerosis: A Narrative Review
2025 · Juan Antonio Flores-Cordero, Amalia Aranaz-Murillo, et al. · NeuroMolecular Medicine · 11
HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients
2017 · Lourdes Hontecillas-Prieto, Daniel J. García-Domínguez, et al. · Oncotarget · 11
Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution
2020 · Helena Castillo-Ecija, Carles Monterrubio, et al. · Journal of Controlled Release · 10
EWS::FLI1-DHX9 interaction promotes Ewing sarcoma sensitivity to DNA topoisomerase 1 poisons by altering R-loop metabolism
2025 · Joaquin Olmedo-Pelayo, Esperanza Granado-Calle, et al. · Oncogene · 9
Leptin a potential link between obesity and depression
2025 · Lourdes Hontecilla-Prieto, Daniel José García-Domínguez, et al. · Cellular and Molecular Life Sciences · 8
PDF
Works count: 42
Citation count: 832
H-index: 16
I10-index: 23
Year
Topic
Type